期刊文献+

HPLC法测定恩杂鲁胺原料药的含量

Determination of enzalutamide crude drug by HPLC
下载PDF
导出
摘要 为建立HPLC法测定恩杂鲁胺原料药的含量,采用Ultimate LP-C18(250×4.6 mm,5μm)色谱柱,以甲醇-0.1%磷酸二氢钾溶液(70∶30)为流动相,流速为1.0 m L/min,进样量为10μL.结果表明,恩杂鲁胺的浓度在12 52μg/m L范围内与峰面积呈现良好的线性关系(r=0.999 2),平均回收率为99.18%100.10%(n=3),RSD为0.4%0.5%.本法具有分析速度快、简单、准确以及专属性强好等特点,适合恩杂鲁胺含量的测定. To establish an HPLC method for the determination of the content of enzalutamide crude drug.Ultimate LP-C18 column( 250 × 4. 6 mm,5 μm) was used. The mobile phase was methonal-0. 1% potassium dihydrogen phosphate solution( 70 ∶ 30). The flow rate was 1. 0 m L·min^-1. The injection volume was 10 μL.The results showed that there was good linearity of enzalutamide in the range of 12—52 μg/m L( r = 0. 999 2).The average recovery was 99. 18% —100. 10%( n = 3),and RSD was 0. 4% —0. 5%. The method was rapid,simple,accurate and specific for the content determination of enzalutamide.
出处 《湖北大学学报(自然科学版)》 CAS 2017年第6期673-676,共4页 Journal of Hubei University:Natural Science
基金 湖北省自然科学基金重点项目(2011CDA048)资助
关键词 恩杂鲁胺 高效液相色谱法 外标法 enzalutamide HPLC external standard method
  • 相关文献

参考文献2

二级参考文献44

  • 1宋丽君,王飏,陆旭芳,李志裕.雄激素受体拮抗剂MDV3100的合成研究[J].精细化工中间体,2012,42(1):34-36. 被引量:7
  • 2崔福德.药剂学[M].北京:人民卫生出版社,2008:311-314.
  • 3Tran C,Ouk S,Clegg N J. Development of a secondgeneration antiandrogen for treatment of advanced prostate cancer[J].Science,2009,(5928):787-790.
  • 4Jung M E,Ouk S,Yoo D. Structure-activity relationship for thiohydantoin androgen receptor antagonists for castrationresistant prostate cancer (CRPC)[J].Journal of Medicinal Chemistry,2010,(07):2779-2796.doi:10.1021/jm901488g.
  • 5Scher H I,Beer T M,Higano C S. Antitumour activity of MDV3100 in castration-resistant prostate cancer:a phase 1-2study[J].Lancet,2010,(9724):1437-1446.
  • 6Ohkanda J,Strickland C L,Blaskovich M A. Structurebased design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase[J].Organic and Biological Chemistry,2006,(03):482-492.doi:10.1039/b508184j.
  • 7Jacobsen E J,TenBrink R E,Stelzer L S. High-affinity partial agonist imidazo[1,5-a]quinoxaline amides,carbamates,and ureas at the gamma-aminobutyric acid A/benzodiazepine receptor complex[J].Journal of Medicinal Chemistry,1996,(01):158-175.doi:10.1021/jm940765f.
  • 8Wong R,Dolman S J. Isothiocyanates from tosyl chloride mediated decomposition of in situ generated dithiocarbamic acid salts[J].Journal of Organic Chemistry,2007,(10):3969-3971.
  • 9Yoshino H,Sato H,Tachibana K. Structure-activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists[J].Bioorganic and Medicinal Chemistry Letters,2010,(09):3159-3168.
  • 10TRAN C,OUK S,CLEGG N,et al. Development of a second generation antiandrogen for treatment of ad- vanced prostate cancer [J]. Science,2009,324(5928).. 787-790.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部